Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF CLINICAL PRACTICE67(3) · pp.236 · 2013
- 피인용
- Web of Science 8
- JCR IF
- JCR 2012 2.427
- ISSN
- 1368-5031
저자
- Hwang, Y. C.제1저자Department Internal Medicine, Kyung Hee University, Kyung Hee University Hospital, South Korea
- Kang, M.Center for Health Promotion, Samsung Medical Center, South Korea
- Ahn, C. W.Department of Internal Medicine, Yonsei University, South Korea
- Park, J. S.Department of Internal Medicine, Yonsei University, South Korea
- Baik, S. H.Department of Internal Medicine, College of Medicine, Korea University, South Korea
- Chung, D. J.Department of Internal Medicine, Chonnam National University, Medical School, South Korea
- Jang, H. C.Department of Internal Medicine, Seoul National University, Bundang Hospital, South Korea
- Kim, K. A.Department of Internal Medicine, University of Dongguk, Ilsan Hospital, South Korea
- Lee, I. K.Department of Internal Medicine, Kyungpook National University, School of Medicine, South Korea
- Min, K. W.Department of Internal Medicine, Eulji University, College of Medicine, South Korea
- Nam, M.Department of Internal Medicine, Inha University, College of Medicine, South Korea
- Park, T. S.Department of Internal Medicine, Chonbuk National University, Medical School, South Korea
- 손석만Department of Internal Medicine, School of Medicine, Pusan National University, South Korea
- Sung, Y. A.Department of Internal Medicine, College of Medicine, Ewha Womans University, South Korea
- Woo, J. T.Department of Endocrinology and Metabolism, Kyung Hee University, School of Medicine, South Korea
- Park, K. S.Department of Internal Medicine, Seoul National University, College of Medicine, South Korea
- Lee, M. K.교신저자Department of Medicine, School of Medicine, Sungkyunkwan University, South Korea
초록
Aims: The study investigated the clinical equivalence in reducing haemoglobin A1c (A1C) between glimepiride/metformin sustained release (GM-SR) 2/500mg, a fixed-dose combination, once daily and glimepiride/metformin (GM) 1/250mg, a fixed-dose combination, twice daily in patients with type 2 diabetes (T2D). Methods: A multicentre, randomised, double-blind, double-dummy study was conducted in 14 hospitals in Korea. Inclusion criteria were age 3075years, T2D diagnosis no longer than 10years previously, A1C between 7% and 10%, and body mass index <40kg/m2. A total of 207 subjects were randomised into the GM-SR group (n=101) or the GM group (n=106). Participants were assessed at baseline, 8weeks and 16weeks after treatment. Results: After 16weeks treatment, no difference in baseline-adjusted changes of A1C (primary efficacy variable) was observed between the two groups (0.59% for GM-SR group vs. 0.61% for GM group, 95% CI: 0.17 to 0.21; p=0.84). In addition, there were no significant differences in secondary efficacy parameters between the two groups, including changes in A1C up to week 8, changes in fasting plasma glucose (FPG) and 2-h-postprandial plasma glucose up to week 8 and week 16, response rate, drug compliance and hypoglycaemic events. However, there was a difference in baseline-adjusted changes of FPG between the two groups (1.01mmol/l for GM-SR group vs. 1.52mmol/l for GM group, p=0.01 in the intention to treat set). Conclusions: GM-SR 2/500mg once daily was as effective as GM 1/250mg twice daily in lowering A1C. In addition, no difference was noted in hypoglycaemic events between the two groups.
키워드
IMPROVED GLYCEMIC CONTROLBLOOD-GLUCOSE CONTROLSULFONYLUREA TREATMENTMETFORMINMELLITUSTHERAPYINSULINCOMPLICATIONSMONOTHERAPYHYPERGLYCEMIA
식별자
- WoS UID
- 000315117700009



로그인
연구물 목록으로